BioXcel Therapeutics公布Serenity居家关键性3期安全试验积极的顶线探索性疗效数据,试验针对双相情感障碍或精神分裂症相关激越症状

美股速递
Sep 10, 2025

BioXcel Therapeutics公布了来自Serenity居家关键性3期安全试验的积极顶线探索性疗效数据,该试验针对双相情感障碍或精神分裂症相关的激越症状进行研究。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10